0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Medicine/Radiopharmaceuticals Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-16103
Home | Market Reports | Health | Pharmacy
Global Nuclear Medicine Radiopharmaceuticals Market Insights Forecast to 2025

Global Nuclear Medicine/Radiopharmaceuticals Market Insights, Forecast to 2025

Code: QYRE-Auto-16103
Report
May 2019
116 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.
The global Nuclear Medicine/Radiopharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine/Radiopharmaceuticals market based on company, product type, end user and key regions.

This report studies the global market size of Nuclear Medicine/Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Medicine/Radiopharmaceuticals in these regions.
This research report categorizes the global Nuclear Medicine/Radiopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Nuclear Medicine/Radiopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    China Isotope & Radiation
    Dongcheng
    Jaco
    Ciaeriar
    Advanced Molecular-imaging Solution
    Shanghai Atom Kexing

Market size by Product
    Diagnostic
    Therapeutic
Market size by End User
    Oncology
    Thyroid
    Cardiology

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Nuclear Medicine/Radiopharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Nuclear Medicine/Radiopharmaceuticals market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Nuclear Medicine/Radiopharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Nuclear Medicine/Radiopharmaceuticals submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceuticals are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine/Radiopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Nuclear Medicine/Radiopharmaceuticals Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Product
        1.4.2 Diagnostic
        1.4.3 Therapeutic
    1.5 Market by End User
        1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by End User
        1.5.2 Oncology
        1.5.3 Thyroid
        1.5.4 Cardiology
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size
        2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue 2014-2025
        2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales 2014-2025
    2.2 Nuclear Medicine/Radiopharmaceuticals Growth Rate by Regions
        2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions
        2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers
        3.1.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers
        3.1.2 Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturers
        3.1.3 Global Nuclear Medicine/Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
    3.2 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers
        3.2.1 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2014-2019)
        3.2.2 Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
    3.3 Nuclear Medicine/Radiopharmaceuticals Price by Manufacturers
    3.4 Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Product Types
        3.4.1 Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
        3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Product
    4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Product
    4.3 Nuclear Medicine/Radiopharmaceuticals Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Nuclear Medicine/Radiopharmaceuticals Breakdown Data by End User

6 North America
    6.1 North America Nuclear Medicine/Radiopharmaceuticals by Countries
        6.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        6.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Nuclear Medicine/Radiopharmaceuticals by Product
    6.3 North America Nuclear Medicine/Radiopharmaceuticals by End User

7 Europe
    7.1 Europe Nuclear Medicine/Radiopharmaceuticals by Countries
        7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Nuclear Medicine/Radiopharmaceuticals by Product
    7.3 Europe Nuclear Medicine/Radiopharmaceuticals by End User

8 Asia Pacific
    8.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Countries
        8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Product
    8.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by End User

9 Central & South America
    9.1 Central & South America Nuclear Medicine/Radiopharmaceuticals by Countries
        9.1.1 Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        9.1.2 Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Nuclear Medicine/Radiopharmaceuticals by Product
    9.3 Central & South America Nuclear Medicine/Radiopharmaceuticals by End User

10 Middle East and Africa
    10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Countries
        10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Product
    10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by End User

11 Company Profiles
    11.1 China Isotope & Radiation
        11.1.1 China Isotope & Radiation Company Details
        11.1.2 Company Business Overview
        11.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products Offered
        11.1.5 China Isotope & Radiation Recent Development
    11.2 Dongcheng
        11.2.1 Dongcheng Company Details
        11.2.2 Company Business Overview
        11.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Products Offered
        11.2.5 Dongcheng Recent Development
    11.3 Jaco
        11.3.1 Jaco Company Details
        11.3.2 Company Business Overview
        11.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Products Offered
        11.3.5 Jaco Recent Development
    11.4 Ciaeriar
        11.4.1 Ciaeriar Company Details
        11.4.2 Company Business Overview
        11.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Products Offered
        11.4.5 Ciaeriar Recent Development
    11.5 Advanced Molecular-imaging Solution
        11.5.1 Advanced Molecular-imaging Solution Company Details
        11.5.2 Company Business Overview
        11.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Products Offered
        11.5.5 Advanced Molecular-imaging Solution Recent Development
    11.6 Shanghai Atom Kexing
        11.6.1 Shanghai Atom Kexing Company Details
        11.6.2 Company Business Overview
        11.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Products Offered
        11.6.5 Shanghai Atom Kexing Recent Development

12 Future Forecast
    12.1 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Regions
        12.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions 2019-2025
        12.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions 2019-2025
    12.2 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Product
        12.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Product 2019-2025
        12.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Product 2019-2025
    12.3 Nuclear Medicine/Radiopharmaceuticals Market Forecast by End User
    12.4 North America Nuclear Medicine/Radiopharmaceuticals Forecast
    12.5 Europe Nuclear Medicine/Radiopharmaceuticals Forecast
    12.6 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Forecast
    12.7 Central & South America Nuclear Medicine/Radiopharmaceuticals Forecast
    12.8 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Nuclear Medicine/Radiopharmaceuticals Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Nuclear Medicine/Radiopharmaceuticals Product Picture
    Table Nuclear Medicine/Radiopharmaceuticals Market Segments
    Table Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Covered
    Table Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Product 2014-2025
    Figure Diagnostic Product Picture
    Table Major Manufacturers of Diagnostic
    Figure Therapeutic Product Picture
    Table Major Manufacturers of Therapeutic
    Table Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Oncology
    Figure Thyroid
    Figure Cardiology
    Figure Nuclear Medicine/Radiopharmaceuticals Report Years Considered
    Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size 2014-2025 (Million US$)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales 2014-2025 (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions 2014-2019 (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions 2014-2019
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions 2014-2019
    Figure 2018 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions 2014-2019 (Million US$)
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions 2014-2019
    Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2014-2019) (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers (2014-2019)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2014-2019) (Million USD)
    Table Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
    Figure Nuclear Medicine/Radiopharmaceuticals Value Share by Manufacturers in 2018
    Table Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Price (2014-2019) (USD/Unit)
    Table Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
    Table Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Product (2014-2019)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Product (2014-2019)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Product in 2018
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Product (2014-2019) (Million US$)
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Product (2014-2019)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Product (2014-2019)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Product in 2018
    Table Nuclear Medicine/Radiopharmaceuticals Price by Product 2014-2019 (USD/Unit)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by End User (2014-2019)
    Figure Global Sales Nuclear Medicine/Radiopharmaceuticals Market Share by End User (2014-2019)
    Figure Global Sales Nuclear Medicine/Radiopharmaceuticals Market Share by End User in 2018
    Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
    Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
    Table North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Product (2014-2019)
    Figure 2018 North America Nuclear Medicine/Radiopharmaceuticals Market Share by Product
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by End User (2014-2019)
    Figure 2018 North America Nuclear Medicine/Radiopharmaceuticals Market Share by End User
    Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure Germany Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure France Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure UK Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Product
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Nuclear Medicine/Radiopharmaceuticals Market Share by End User
    Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure China Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure China Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure India Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Share by Product
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Share by End User
    Figure Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure Brazil Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Share by Product
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Share by End User
    Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure GCC Countries Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Share by Product
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Share by End User
    Table China Isotope & Radiation Company Details
    Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table China Isotope & Radiation Recent Development
    Table Dongcheng Company Details
    Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Dongcheng Recent Development
    Table Jaco Company Details
    Table Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Jaco Recent Development
    Table Ciaeriar Company Details
    Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Ciaeriar Recent Development
    Table Advanced Molecular-imaging Solution Company Details
    Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Advanced Molecular-imaging Solution Recent Development
    Table Shanghai Atom Kexing Company Details
    Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Shanghai Atom Kexing Recent Development
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Regions 2019-2025
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Regions 2019-2025
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Product 2019-2025 (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Product 2019-2025
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Product 2019-2025
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by End User 2019-2025 (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by End User 2019-2025
    Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Nuclear Medicine/Radiopharmaceuticals Value Chain
    Table Nuclear Medicine/Radiopharmaceuticals Customers List
    Table Nuclear Medicine/Radiopharmaceuticals Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

China Diclofenac Sodium and Codeine Phosphate Tablets Market Report Forecast 2021 2027
China Diclofenac Sodium and Codeine Phosphate Tablets Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-23N6694
Tue Oct 26 00:00:00 UTC 2021

Add to Cart

Global and United States Ophthalmic Viscoelastic Devices OVDs Market Insights Forecast to 2027
Global and United States Ophthalmic Viscoelastic Devices (OVDs) Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-6J7152
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

Global and United States Latex Tourniquet Market Insights Forecast to 2027
Global and United States Latex Tourniquet Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-8X7025
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

Global and United States Viral Conjunctivitis Pipeline Drugs Market Insights Forecast to 2027
Global and United States Viral Conjunctivitis Pipeline Drugs Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34B6632
Mon Oct 25 00:00:00 UTC 2021

Add to Cart